First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis
No Thumbnail Available
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Description
Keywords
Turkish CoHE Thesis Center URL
WoS Q
Q1
Scopus Q
Q1
Source
ESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN
Volume
33
Issue
Start Page
S281
End Page
S281